Africa & Middle East

In 2025, an estimated 11.5 million people living with HIV worldwide were aged 50 and above, representing approximately 29% of the global population living with the virus.

The collaboration will focus on connecting business functions, improving access to information and using emerging technologies, including artificial intelligence (AI), to support faster decision-making across the Group.

Under the agreement, Mediclinic Middle East will engage with HealthTech startups within Hub71+ Life Sciences to identify potential collaborations and provide clinical guidance.

Under the agreement, ADSCC will contribute its cell therapy development and manufacturing infrastructure, while Miltenyi will provide scientific and technical support for its proprietary viral vector and anti-CD19 chimeric antigen receptor technologies.

Mediclinic Middle East is exploring how ambient AI can capture relevant information from clinician-patient conversations and convert it into structured clinical notes for review, reducing the need for manual documentation during consultations.

The project will increase inpatient and outpatient capacity, upgrade existing departments and introduce new orthopaedic and physiotherapy services.

The women’s health and fertility portfolio will cover several stages of reproductive health, including fertility, pregnancy and childbirth.

The partnership was formalized through a memorandum of understanding (MoU) at the Abu Dhabi Future Health Summit 2026.

The clinic brings together specialists in surgery, oncology, radiology, and reconstruction, along with nursing and patient coordination services.

The meeting combines an African subregional workshop with the closing session of the Global Environment Facility’s (GEF) GEF-7 Phasing Down Dental Amalgam Project.